Skip to content

Fertilizations With Immotile Sperm: Pentoxyphylline Activation Alone, or With Chemical Oocyte Activation

A Randomized Controlled Trial to Compare Fertilizations With Immotile Sperm After Pentoxyphylline Activation Alone, or With Chemical Oocyte Activation

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02051075
Acronym
PXN
Enrollment
0
Registered
2014-01-31
Start date
2014-03-31
Completion date
2015-05-31
Last updated
2015-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

IVF, ICSI, Asthenospermia, pentoxyphylline, Spermatozoa

Brief summary

Immotile sperm is a rather frequent problem encountered in IVF patients. Treatment is usually based on inducing motility with pentoxyphylline (PXN) followed by ICSI. However, fertilization rate with this method is still lower compared with ICSI using motile sperm. One of the reasons for that is the immotile sperm inability to activate the oocyte Our research hypothesis is that better fertilization rate can be accomplished in these cases by combining PXN sperm activation with Ca ionophore oocyte activation.

Interventions

BIOLOGICALPXN sperm treatment

immotile sperm activation with PXN

BIOLOGICALSperm activation with PXN and oocyte activation

Sponsors

Rambam Health Care Campus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* Women up to 35 years of age * immotile sperm * At least 6 mature eggs

Exclusion criteria

* globozoospermia * Freeze all cycles because of OHSS risk.

Design outcomes

Primary

MeasureTime frameDescription
Clinical pregnancyOne month post oocyte retrievalDemonstration of fetal heart activity 1 month post oocyte retrieval.

Secondary

MeasureTime frameDescription
Fertilization rateOne day post oocyte retrievalNormal, 2 pronuclei, zygote one day post ICSI

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026